EUVIMEDEUVIMED entdecken
Vergleichsstudie

Secnidazole and metronidazole in the treatment of Trichomoniasis: Comparative study of the mechanism of action and development of innovative 3D printed intrauterine devices

Ágata Giuseppe Menezes, Fernanda Gomes Cardoso, Giulia Bongiorni Galego, Lenon Machado Alves, Marcelo Dutra Arbo, Solange Cristina Garcia, Maiara Callegaro Velho, Janine Boniatti, Ruy Carlos Ruver Beck, Tiana Tasca

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2025.108222 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Ágata Giuseppe Menezes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Pesquisa Em Tricomonas, Faculdade de Farmácia e Centro de Biotecnologia, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil…. Hauptthemen laut MEDLINE: Metronidazole, Trichomonas vaginalis, Printing, Three-Dimensional, Intrauterine Devices. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Foundation for Research Support of Rio Grande do Sul State.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trichomonas vaginalis is the causative agent of trichomoniasis, the most prevalent non-viral sexually transmitted infection (STI) worldwide. This study aimed to evaluate the susceptibility of five T. vaginalis isolates to secnidazole and metronidazole - two of the three FDA-approved treatments. We also investigated their mechanisms of action and explored the use of 3D printing technology for delivering anti-T. vaginalis therapy. In vitro susceptibility assays were performed using secnidazole and metronidazole. To investigate their mechanisms of action, we assessed reactive oxygen and nitrogen species (ROS/RNS) production, lipid peroxidation, type of cell death, and superoxide dismutase (SOD) gene expression by qRT-PCR. DNA integrity was evaluated using the comet assay. Additionally, we designed 3D-printed intrauterine devices (IUDs) loaded with each drug to evaluate their efficacy in eradicating T. vaginalis. All isolates were more susceptible to secnidazole than to metronidazole. Neither drug increased ROS/RNS levels or lipid peroxidation. However, both downregulated SOD expression in most isolates and induced apoptosis-like cell death, evidenced by phosphatidylserine exposure. No DNA strand breaks were detected. Drug-loaded 3D-printed IUDs eradicated T. vaginalis trophozoites within 24 h, with secnidazole achieving this effect as early as 10 h post-treatment. Secnidazole and metronidazole appear to disrupt redox homeostasis through a mechanism independent of ROS/RNS, likely by downregulating SOD and increasing cellular susceptibility to oxidative stress. Both drugs induced apoptosis-like cell death without causing DNA damage. The drug-loaded devices represent a promising strategy for localized and personalized treatment. This is the first proof-of-concept for a 3D-printed IUD loaded with secnidazole and metronidazole demonstrating trichomonacidal action and highlighting a novel, localized drug delivery strategy with potential applications in personalized medicine for the treatment of trichomoniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleTrichomonas vaginalisPrinting, Three-DimensionalIntrauterine DevicesAntiprotozoal AgentsTrichomonas InfectionsHumansFemaleReactive Oxygen SpeciesSuperoxide DismutaseLipid PeroxidationParasitic Sensitivity TestsApoptosis

Stichwörter der Autor:innen

3D printed IUDApoptosis-likeMetronidazoleSecnidazoleSuperoxide dismutaseTrichomonas vaginalis

Substanzen

MetronidazoleReactive Oxygen SpeciessecnidazoleAntiprotozoal AgentsSuperoxide Dismutase

Autor:innen und Institutionen

  • Grupo de Pesquisa Em Tricomonas, Faculdade de Farmácia e Centro de Biotecnologia, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil; Programa de Pós-Graduação Em Ciências Farmacêuticas, Universidade Fe…
  • Laboratório de Toxicologia, Departamento de Análises, Faculdade de Farmácia, Universidade Federal Do Rio Grande Do Sul - UFRGS, Porto Alegre, RS, Brazil.
  • Laboratório de Toxicologia, Departamento de Análises, Faculdade de Farmácia, Universidade Federal Do Rio Grande Do Sul - UFRGS, Porto Alegre, RS, Brazil; Programa de Pós-Graduação Em Ciências Farmacêuticas, Universidade…
  • Laboratório de Nanocarreadores e Impressão 3D Em Tecnologia Farmacêutica (Nano3D), Faculdade de Farmácia, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil; Programa de Pós-Graduação Em Ciências Farmac…
  • Plataforma de Bioinovações 3D - RTP18C, Rede de Plataformas Tecnológicas (RPT), Vice-presidência de Pesquisa e Coleções Biológicas (VPPCB), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.

Förderung

  • National Council for Scientific and Technological Development
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Foundation for Research Support of Rio Grande do Sul State

Zitieren

APA

Menezes, Á. G., Cardoso, F. G., Galego, G. B., Alves, L. M., Arbo, M. D., Garcia, S. C., Velho, M. C., Boniatti, J., Beck, R. C. R., & Tasca, T. (2026). Secnidazole and metronidazole in the treatment of Trichomoniasis: Comparative study of the mechanism of action and development of innovative 3D printed intrauterine devices. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.108222

Vancouver

Menezes ÁG, Cardoso FG, Galego GB, Alves LM, Arbo MD, Garcia SC, et al. Secnidazole and metronidazole in the treatment of Trichomoniasis: Comparative study of the mechanism of action and development of innovative 3D printed intrauterine devices. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2025.108222

BibTeX
@article{Menezes2026,
  author = {Menezes, Ágata Giuseppe and Cardoso, Fernanda Gomes and Galego, Giulia Bongiorni and Alves, Lenon Machado and Arbo, Marcelo Dutra and Garcia, Solange Cristina and Velho, Maiara Callegaro and Boniatti, Janine and Beck, Ruy Carlos Ruver and Tasca, Tiana},
  title = {Secnidazole and metronidazole in the treatment of Trichomoniasis: Comparative study of the mechanism of action and development of innovative 3D printed intrauterine devices},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2025.108222}
}
Kostenlos starten →